MedTrace Logo

Long-term Morbidity After Surgery for Perihilar Cholangiocarcinoma

NCT03999593 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-12-17

No results posted yet for this study

Summary

Surgery for perihilar cholangiocarcinoma offers the only possibility of long-term survival, but remains a formidable undertaking. Traditionally, 90 day post-operative complications and death have been used to define operative risk. However, there is concern that this metric may not accurately capture long-term morbidity after such complex surgery.

This is a retrospective review of a prospective database of patients undergoing surgery for perihilar cholangiocarcinoma at a Western centre between 2009-2017.

Conditions

Interventions

PROCEDURE

Resection of perihilar cholangiocarcinoma

Resection of perihilar cholangiocarcinoma

Sponsors & Collaborators

  • University of Liverpool

    lead OTHER

Principal Investigators

  • Robert Jones · University of Liverpool

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2017-10-31
Completion
2017-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03999593 on ClinicalTrials.gov